Inventors sweating over their next big idea—especially in AI-driven fintech—wake up to a brutal reality. Your patent application’s toast if it veers too close to monopolizing a basic building block of innovation, no matter how clever the spin.
That’s the sting from the Federal Circuit’s latest smackdown in Solutran v. Elavon. Real people? Think scrappy startups pouring cash into R&D, only to see courts shred their claims for reciting ‘abstract ideas’ like electronic check processing. It’s not just legalese; it’s venture funding evaporating, teams disbanding.
But here’s the thing. Courts keep blurring lines between preemption and novelty/non-obviousness, leaving everyone dazed. Solutran’s patent? Dead under 35 U.S.C. §101, despite arguments it was inventive.
Why Does Novelty Alone Fail the §101 Test?
The Federal Circuit didn’t mince words. They straight-up dismissed the novelty defense:
“We have previously explained that merely reciting an abstract idea by itself in a claim—even if the idea is novel and non-obvious—is not enough to save it from ineligibility.”
Ouch. This echoes Intellectual Ventures v. Symantec, where a jury’s nod to non-obviousness meant zilch for eligibility. Novel? Sure. Non-obvious? Jury agreed. Still ineligible.
Look, patent folks know §102 and §103 guard against the mundane. But §101? That’s the gatekeeper against overreach. And preemption lurks underneath, the real enforcer.
It started way back—1853, O’Reilly v. Morse. Samuel Morse tried claiming electromagnetism for printing characters, sans specifics. Supreme Court? Nope. You’re hogging a natural force, scaring off improvers. Sound familiar? Swap electromagnetism for ‘neural networks processing data,’ and you’ve got today’s AI patent woes.
My unique angle: this isn’t evolution; it’s a callback to Morse in the machine-learning era. Courts fear broad AI claims preempting entire domains—like ‘using transformers for prediction’—echoing Morse’s electromagnetic blanket. Bold prediction? We’ll see §101 challenges spike for genAI tools unless drafters bolt on hyper-specific integrations.
How Does Preemption Actually Work in Practice?
Preemption isn’t some vague boogeyman. Supreme Court nailed it in Mayo v. Prometheus: don’t patent the ‘building blocks’ of ingenuity.
“In applying the §101 exception, this Court must distinguish patents that claim the ‘’buildin[g] block[s]’’ of human ingenuity, which are ineligible for patent protection, from those that integrate the building blocks into something more.”
Inventive concept? Not your garden-variety novelty. It’s elements ensuring the claim is ‘significantly more’ than the abstract idea itself. A tweak here, a conventional step there—doesn’t cut it.
Solutran’s claims? Electronically scanning checks, verifying funds pre-clearing. Sounds techy. Nope—pure abstract idea, no transformative alchemy.
And courts blur terms. Federal Circuit opinions mash preemption talk with obviousness nods, confusing everyone. Why? Because preemption’s the why behind §101’s bite: stop inventors from fencing off fundamentals, even if they’re first to the party.
Consider the district court in Solutran—it bought the novelty pitch. Reversed on appeal. Pattern holds: eligibility trumps §§102/103 every time.
Short para: Preemption wins.
Now, drill deeper. Mayo redefined ‘inventive concept’—not newness, but integration. Claim a law of nature? Add zilch? Preempted. Same for abstract ideas: math, methods, mental steps.
AI inventors, listen up. Your ‘novel algorithm for fraud detection’? If it’s just applying math to data without tech-specific guts—like custom hardware or non-generic software limits—you’re preempting detection itself.
Historical parallel amps this: Morse lost for claiming the ‘use’ of electromagnetism broadly. Today? Claims to ‘using blockchain for transactions’ sans structure? Same fate. Corporate PR spins these as ‘business method protections,’ but courts see monopoly grabs.
What Happens If Courts Keep Blurring These Lines?
Chaos for drafters. Patents greenlit on novelty get invalidated later, eroding trust. Startups pivot to trade secrets—fine short-term, deadly for scaling.
Yet silver lining. Grasp preemption, and you architect around it. Bolt claims to specific, unconventional integrations—quantum-resistant crypto on edge devices, say. That’s ‘more.’
Federal Circuit’s Solutran punt reinforces Alice/Mayo step two: does it add enough? Novelty’s irrelevant there.
One sentence wonder: Rewrite with preemption in mind.
Longer riff: We’ve seen this in biotech (Myriad’s natural DNA), software (DDR’s widget tracking). Each time, courts probe: does this preempt the idea’s use everywhere? If yes, ineligible—even if no prior art touches it.
Critique the spin: Patent Bar cheers ‘clarity,’ but it’s muddy. Terms bleed; opinions cite preemption then pivot to obviousness. Result? Inconsistent applications, ripe for SCOTUS redux.
🧬 Related Insights
- Read more: Alibaba’s Accio AI Slashes Costs for Small Sellers—But at What Price?
- Read more: Americans Swarm to AI Tools—But 76% Wouldn’t Trust Them with Real Stakes
Frequently Asked Questions
What is preemption in patent eligibility?
Preemption means claiming laws of nature, abstract ideas, or basics so broadly you block others from building on them—core §101 worry since Morse.
Does novelty protect against §101 invalidation?
Nope—Federal Circuit says explicitly: novel abstract ideas still fail without ‘significantly more.’
How can AI patents beat §101?
Integrate ideas into specific, non-generic tech applications—avoid broad ‘use of ML for X’ sweeps.
